Literature DB >> 9088523

Can we predict aggressive disease?

A Young1, D M van der Heijde.   

Abstract

This chapter will describe the reasons why prognostic factors that predict aggressive disease are helpful and what the problems are in interpreting studies in this field. A summary of cohort studies on prognosis of patients with early rheumatoid arthritis are presented. This is done separately for studies predicting radiographic damage, functional outcome and mortality. The overall conclusions of these studies and the value they have for the clinician are demonstrated.

Entities:  

Mesh：

Year:  1997        PMID： 9088523     DOI： 10.1016/s0950-3579(97)80031-3

Source DB:  PubMed          Journal:  Baillieres Clin Rheumatol        ISSN： 0950-3579


  10 in total

1.  Markers of joint destruction: principles, problems, and potential.

Authors:  S A Young-Min; T E Cawston; I D Griffiths
Journal:  Ann Rheum Dis       Date:  2001-06       Impact factor: 19.103

2.  Treatment strategy, disease activity, and outcome in four cohorts of patients with early rheumatoid arthritis.

Authors:  J M Albers; L Paimela; P Kurki; K B Eberhardt; P Emery; M A van 't Hof; F H Schreuder; M Leirisalo-Repo; P L van Riel
Journal:  Ann Rheum Dis       Date:  2001-05       Impact factor: 19.103

3.  Combination therapy in early rheumatoid arthritis: a randomised, controlled, double blind 52 week clinical trial of sulphasalazine and methotrexate compared with the single components.

Authors:  M Dougados; B Combe; A Cantagrel; P Goupille; P Olive; M Schattenkirchner; S Meusser; L Paimela; R Rau; H Zeidler; M Leirisalo-Repo; K Peldan
Journal:  Ann Rheum Dis       Date:  1999-04       Impact factor: 19.103

Review 4.  Etanercept: an updated review of its use in rheumatoid arthritis, psoriatic arthritis and juvenile rheumatoid arthritis.

Authors:  Christine R Culy; Gillian M Keating
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 5.  Measuring the effects of medication use on health-related quality of life in patients with rheumatoid arthritis. A review.

Authors:  M B Nichol; A S Harada
Journal:  Pharmacoeconomics       Date:  1999-11       Impact factor: 4.981

6.  Socioeconomic deprivation and rheumatoid disease: what lessons for the health service? ERAS Study Group. Early Rheumatoid Arthritis Study.

Authors: 
Journal:  Ann Rheum Dis       Date:  2000-10       Impact factor: 19.103

7.  Which patients stop working because of rheumatoid arthritis? Results of five years' follow up in 732 patients from the Early RA Study (ERAS).

Authors:  A Young; J Dixey; E Kulinskaya; N Cox; P Davies; J Devlin; P Emery; A Gough; D James; P Prouse; P Williams; J Winfield
Journal:  Ann Rheum Dis       Date:  2002-04       Impact factor: 19.103

8.  Only high disease activity and positive rheumatoid factor indicate poor prognosis in patients with early rheumatoid arthritis treated with "sawtooth" strategy.

Authors:  T Möttönen; L Paimela; M Leirisalo-Repo; H Kautiainen; J Ilonen; P Hannonen
Journal:  Ann Rheum Dis       Date:  1998-09       Impact factor: 19.103

9.  Prognostic laboratory markers of joint damage in rheumatoid arthritis.

Authors:  E Lindqvist; K Eberhardt; K Bendtzen; D Heinegård; T Saxne
Journal:  Ann Rheum Dis       Date:  2004-09-30       Impact factor: 19.103

Review 10.  Structural damage in rheumatoid arthritis as visualized through radiographs.

Authors:  Désirée van der Heijde
Journal:  Arthritis Res       Date:  2002-03-27
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.